0.3349
price down icon1.47%   -0.005
 
loading

IGC Pharma Inc (IGC) 最新ニュース

pulisher
08:30 AM

IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor - Morningstar

08:30 AM
pulisher
Jan 14, 2025

Geode Capital Management LLC Has $240,000 Stock Holdings in IGC Pharma, Inc. (NYSEMKT:IGC) - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets - Macon Telegraph

Jan 13, 2025
pulisher
Jan 13, 2025

IGC Pharma to Unveil Alzheimer's Pipeline and AI Drug Discovery Updates at Investor Chat - StockTitan

Jan 13, 2025
pulisher
Jan 08, 2025

Amazon To Sell Ad Tools To Third Parties - Baystreet.ca

Jan 08, 2025
pulisher
Jan 08, 2025

IGC Gains on Word of Alzheimer’s Treatment - Baystreet.ca

Jan 08, 2025
pulisher
Jan 08, 2025

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy - AccessWire

Jan 08, 2025
pulisher
Jan 08, 2025

IGC Pharma's CALMA Trial Triples Alzheimer's Patient Recruitment with AI-Powered Strategy - StockTitan

Jan 08, 2025
pulisher
Dec 19, 2024

IGC Pharma to Present at BIO Partnering @ JPM 2025 Healthcare Conference - StockTitan

Dec 19, 2024
pulisher
Dec 19, 2024

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 - AccessWire

Dec 19, 2024
pulisher
Dec 18, 2024

What Makes IGC Pharma, Inc. (IGC) a New Buy Stock - MSN

Dec 18, 2024
pulisher
Dec 07, 2024

Ascendiant Capital Markets Forecasts Strong Price Appreciation for IGC Pharma (NYSEMKT:IGC) Stock - Defense World

Dec 07, 2024
pulisher
Dec 02, 2024

IGC Pharma expands clinical research program for IGC-AD1 - Nasdaq

Dec 02, 2024
pulisher
Dec 02, 2024

IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology - AccessWire

Dec 02, 2024
pulisher
Dec 02, 2024

IGC Pharma's Alzheimer's Drug Shows 50% Memory Improvement in Early Studies - StockTitan

Dec 02, 2024
pulisher
Nov 30, 2024

IGC.WS (India Globalization Capital) EV-to-FCF : 0.00 (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 27, 2024

Otsuka Corp (OSUKF) QuotePress Release - The Globe and Mail

Nov 27, 2024
pulisher
Nov 26, 2024

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial - Inkl

Nov 26, 2024
pulisher
Nov 25, 2024

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment - BioSpace

Nov 25, 2024
pulisher
Nov 25, 2024

IGC Pharma's Alzheimer's Drug Shows 8% Cognitive Improvement in Phase 2 Trial - StockTitan

Nov 25, 2024
pulisher
Nov 24, 2024

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of He - GuruFocus.com

Nov 24, 2024
pulisher
Nov 21, 2024

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasin - GuruFocus.com

Nov 21, 2024
pulisher
Nov 15, 2024

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline - WSIL TV

Nov 15, 2024
pulisher
Nov 14, 2024

IGC (IGC Pharma) Price-to-Operating-Cash-Flow : (As of Nov. 14, 2024) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 12, 2024

IGC Pharma Reports 42% Revenue Growth, Advances Multiple Alzheimer's Drug Candidates | IGC Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 06, 2024

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies - AccessWire

Nov 06, 2024
pulisher
Nov 06, 2024

IGC Pharma CEO Reveals AI-Driven Strategy in Alzheimer's and Weight Loss Drug Development | IGC Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 03, 2024

IGC Pharma (STU:IGS1) Asset Turnover : 0.03 (As of Jun. 2024) - GuruFocus.com

Nov 03, 2024
pulisher
Oct 17, 2024

MD’s IGC Pharma enrolls patients in Phase 2 trial for Alzheimer’s dementia drug - Maryland Daily Record

Oct 17, 2024
pulisher
Oct 17, 2024

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1 - AccessWire

Oct 17, 2024
pulisher
Oct 13, 2024

Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts - Seeking Alpha

Oct 13, 2024
pulisher
Oct 08, 2024

A Guide To The Risks Of Investing In IGC Pharma Inc (IGC) - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Investor’s Delight: IGC Pharma Inc (IGC) Closes Strong at 0.37, Up 0.13 - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Was IGC Pharma Inc (IGC)’s session last reading good? - US Post News

Oct 08, 2024
pulisher
Oct 05, 2024

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Stockholders’ Approval of All Disclosed Proposals at 2024 Annual Meeting - MSN

Oct 05, 2024
pulisher
Oct 03, 2024

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge - Markets Insider

Oct 03, 2024
pulisher
Oct 03, 2024

Financial Metrics Check: IGC Pharma Inc (IGC)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 03, 2024
pulisher
Oct 01, 2024

A Look at IGC Pharma Inc (IGC) Shares in the Recent Past Indicates Growth - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

IGC Pharma Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

IGC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

Is IGC Pharma Inc (AMEX:IGC) stock a better investment at this time? - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

AvePoint Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

IGC Pharma Inc (AMEX: IGC) Down -0.99% This Year: What Is Going To Happen Next - Stocks Register

Sep 30, 2024
pulisher
Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock - Investing.com Australia

Sep 27, 2024
pulisher
Sep 27, 2024

IGC Pharma director James Moran buys $200k in company stock By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 24, 2024

Ipca Labs shares hit lifetime high after Nomura raises target price - Business Standard

Sep 24, 2024
$35.40
price up icon 4.08%
$73.75
price up icon 2.45%
$21.55
price up icon 13.14%
$362.62
price up icon 1.02%
biotechnology ONC
$218.44
price up icon 3.95%
$111.91
price up icon 0.02%
大文字化:     |  ボリューム (24 時間):